ASCEND BY NTHRYS
Research Abroad Products

Cancer Systems Biology Project Topics

Browse all focused areas across all project categories under this field.

Showing 25–36 of 200 project topics
Resistance Mutation Prediction Engine for Cancer Drugs
An AI system that predicts secondary mutations likely to confer drug resistance in kinase inhibitor-treated tumors before they emerge clinically. Delivers measurable value to pharma companies through improved clinical trial design and post-market surveillance contracts.
Cancer Signaling Pathway Drug Design Tools Click to view more details →
Multi-Omics Integration Platform for Signaling Network Reconstruction
Enterprise platform that combines proteomics, phosphoproteomics, transcriptomics, and metabolomics data to build comprehensive cancer signaling networks specific to tumor subtypes. Generates revenue through data processing services, custom network modeling, and technology licensing to CROs and biotech.
Cancer Signaling Pathway Drug Design Tools Click to view more details →
Synthetic Lethal Interaction Discovery Commercial Service
A computational screening service that identifies synthetic lethal partners for mutated cancer genes using pathway databases and machine learning models. Operates as a fee-for-service business model generating $1M+ annually from pharma and biotech partnerships targeting combination therapies.
Cancer Signaling Pathway Drug Design Tools Click to view more details →
Immunotherapy Response Biomarker Prediction SaaS Platform
Software that models T-cell receptor interactions with tumor neoantigens by integrating cancer signaling pathways and immune checkpoint biology data. Monetizes through per-patient biomarker prediction fees ($300-600) and licensing to immunotherapy developers and clinical labs.
Cancer Signaling Pathway Drug Design Tools Click to view more details →
Rational Drug Combination Design Optimization Engine
Platform that uses systems biology modeling to design synergistic drug combinations targeting interconnected cancer signaling nodes and feedback loops. Delivers licensing revenue from Big Pharma partners pursuing combination therapy development and personalizes recommendations via per-case analysis fees.
Cancer Signaling Pathway Drug Design Tools Click to view more details →
Tumor Microenvironment-Pathway Interaction Modeling Toolkit
Commercial toolkit that models crosstalk between cancer cell signaling pathways and stromal/immune cell-derived signals in the tumor niche. Generates recurring revenue through software licensing, consulting services, and integration partnerships with digital pathology and spatial omics platforms.
Cancer Signaling Pathway Drug Design Tools Click to view more details →
Real-Time Clonal Tracking SaaS Platform
A cloud-based analytics platform that monitors tumor clonal composition and evolutionary trajectories using multi-region sequencing data in real time. Enables oncologists to make treatment pivots earlier and improves patient stratification, generating recurring subscription revenue from hospitals and research institutions.
Tumor Evolution & Clonal Dynamics Modeling Click to view more details →
Predictive Mutation Driver Discovery Tool
Software that identifies emerging driver mutations and predicts treatment resistance before clonal expansion through machine learning models trained on evolutionary patterns. Delivers value to pharmaceutical companies by accelerating drug target identification and reducing development costs.
Tumor Evolution & Clonal Dynamics Modeling Click to view more details →
Tumor Phylogenetic Reconstruction Service
A professional services offering that reconstructs complete tumor evolutionary trees from genomic data using advanced computational phylogenetics. Generates revenue through per-sample analysis fees and supports precision oncology diagnostics for clinical labs and academic centers.
Tumor Evolution & Clonal Dynamics Modeling Click to view more details →
Clonal Selection Simulation Engine
A computational tool that models clonal competition dynamics under different treatment regimens using evolutionary game theory and stochastic simulations. Creates licensing opportunities for pharma companies designing combination therapies and resistance prevention strategies.
Tumor Evolution & Clonal Dynamics Modeling Click to view more details →
Heterogeneity-Aware Patient Stratification Platform
Enterprise software that quantifies intra-tumor heterogeneity and assigns patients to precision treatment cohorts based on clonal complexity metrics. Enables biotech firms to improve trial enrollment and patient outcomes while creating data licensing partnerships.
Tumor Evolution & Clonal Dynamics Modeling Click to view more details →
Single-Cell Clonal Barcode Analysis Suite
Integrated software for processing and analyzing clonal barcode data from single-cell sequencing experiments to track individual clone dynamics. Provides revenue through software licensing and custom analysis services to research institutes and clinical genomics centers.
Tumor Evolution & Clonal Dynamics Modeling Click to view more details →